Home Sectors Healthcare Current Trend: Pfizer (NYSE: PFE)

Current Trend: Pfizer (NYSE: PFE)

21
0
SHARE

Pfizer trades as part of the drug manufacturers industry and is part of the healthcare sector. The company CEO is Ian C. Read. Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.

Previous Intraday Trading Performance:

The PFE stock showed a previous change of 0.14% with an open at 37.26 and a close of 37.16. It reached an intraday high of 37.47 and a low of 37.01.

SeekingAlpha:  Vaccinex files for $46M initial public offering

Liquidity:

The stock has a market cap of $217.4b with 5.8b shares outstanding, of which the float is 5.8b shares. Trading volume reached 21,092,585 shares compared to its average volume of 20,876,658 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Pfizer shares returned 2.28% and in the past 30 trading days it returned 4.15%. Over three months, it changed 5.82%. In one year it has changed 15.50% and within that year its 52-week high was 39.43 and its 52-week low was 32.32. PFE stock is 14.98% above its 52 Week Low.

Our calculations show a 200 day moving average of 35.57 and a 50 day moving average of 35.97. Currently PFE stock is trading 4.46% above its 200 day moving average and may be a good opportunity to buy.

CNBC:  Trump says Pfizer, others 'should be ashamed' for raising drug prices

Earnings:

The last annual fiscal EPS for the company was reported at 3.52 that ended on 31st of December 2017, which according to the previous close, that is a PE of 10.56. Based on 6 analyst estimates, the consensus EPS for the next quarter is 0.75. The TTM EPS is 2.73, which comes to a TTM PE of 13.61. Historically, the PE high was 33.70 and the PE low was 8.70. If the stock reached its PE low, that would represent a price of 23.75, which is a decrease of -36.08%.

The following are the last four quarter reported earnings per share:
03-31-2018:  0.77
12-31-2017:  0.62
09-30-2017:  0.67
06-30-2017:  0.67

The dividend per share is currently 1.36, which is a dividend yield of 3.66%. Also, the payout ratio is 49.82%, therefore the dividend is safe according to our calculations.

Base on our calculations, the intrinsic value per share is 64.02, which means it is possibly undervalued and has a margin of safety of 41.96%

Indicators to Watch:

Based on the latest filings, there is 73.40% of institutional ownership. Short-interest is 64,685,349, which is 1.11% of shares outstanding. The short-interest ratio or days-to-cover ratio is 3.26. This stock has some short interest, but it may be normal and no cause for concern if long the position.

The current calculated beta is 0.93

SeekingAlpha:  Sangamo: Foundational Platform's Path To Clinical Validation

Fundamental Indicators:

Based on last reported financials, the company's return on equity is 31.57%, return on assets is 12.08%, profit margin is 48.01%, price-to-sales is 5.46 and price-to-book is 3.09.

Company Scores:

All scores are out of six:
 5  :Valuation Score
 5  :Past Performance Score
 3  :Financial Strength Score
 1  :Future Growth Score
 4  :Dividend Score
 3  :Overall Score

SHARE
John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks. Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.

LEAVE A REPLY

Please enter your comment!
Please enter your name here